These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 17374330

  • 1. [Expression of galanin in melanocytic tumors].
    Gilaberte Y, Vera J, Coscojuela C, Roca MJ, Parrado C, González S.
    Actas Dermosifiliogr; 2007; 98(1):24-34. PubMed ID: 17374330
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide Y expression in cutaneous melanoma.
    Gilaberte Y, Roca MJ, Garcia-Prats MD, Coscojuela C, Arbues MD, Vera-Alvarez JJ.
    J Am Acad Dermatol; 2012 Jun; 66(6):e201-8. PubMed ID: 21620518
    [Abstract] [Full Text] [Related]

  • 3. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
    Clarke LE, Fountaine TJ, Hennessy J, Bruggeman RD, Clarke JT, Mauger DT, Helm KF.
    J Cutan Pathol; 2009 Apr; 36(4):433-8. PubMed ID: 19278428
    [Abstract] [Full Text] [Related]

  • 4. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
    Busam KJ, Iversen K, Berwick M, Spagnoli GC, Old LJ, Jungbluth AA.
    Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815
    [Abstract] [Full Text] [Related]

  • 5. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J, Cronin F, Duncan LM.
    Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein D expression in cutaneous malignant melanoma.
    Miranda E, Vizoso F, Martín A, Quintela I, Corte MD, Seguí ME, Ordiz I, Merino AM.
    J Surg Oncol; 2003 Jun; 83(2):99-105. PubMed ID: 12772203
    [Abstract] [Full Text] [Related]

  • 7. Expression of estrogen receptor beta in normal skin, melanocytic nevi and malignant melanomas.
    Ohata C, Tadokoro T, Itami S.
    J Dermatol; 2008 Apr; 35(4):215-21. PubMed ID: 18419678
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
    Miracco C, De Nisi MC, Arcuri F, Cosci E, Pacenti L, Toscano M, Lalinga AV, Biagioli M, Rubegni P, Vatti R, Maellaro E, Del Bello B, Massi D, Luzi P, Tosi P.
    Int J Oncol; 2006 Feb; 28(2):345-52. PubMed ID: 16391788
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A, McNutt NS.
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [Abstract] [Full Text] [Related]

  • 12. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?
    Kaleem Z, Lind AC, Humphrey PA, Sueper RH, Swanson PE, Ritter JH, Wick MR.
    Mod Pathol; 2000 Mar; 13(3):217-22. PubMed ID: 10757331
    [Abstract] [Full Text] [Related]

  • 13. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms.
    Cohn ML, Goncharuk VN, Diwan AH, Zhang PS, Shen SS, Prieto VG.
    J Cutan Pathol; 2005 Sep; 32(8):533-6. PubMed ID: 16115050
    [Abstract] [Full Text] [Related]

  • 14. Nestin expression in cutaneous melanomas and melanocytic nevi.
    Brychtova S, Fiuraskova M, Hlobilková A, Brychta T, Hirnak J.
    J Cutan Pathol; 2007 May; 34(5):370-5. PubMed ID: 17448190
    [Abstract] [Full Text] [Related]

  • 15. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR, El-Zammar O.
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [Abstract] [Full Text] [Related]

  • 16. G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas.
    Stefanaki C, Stefanaki K, Antoniou C, Argyrakos T, Stratigos A, Patereli A, Katsambas A.
    J Cutan Pathol; 2008 Sep; 35(9):799-808. PubMed ID: 18494826
    [Abstract] [Full Text] [Related]

  • 17. [Thermographic examination of cutaneous melanocytic nevi].
    Mikulska D.
    Ann Acad Med Stetin; 2009 Sep; 55(1):31-8; discussion 38. PubMed ID: 20349589
    [Abstract] [Full Text] [Related]

  • 18. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
    Massi D, Naldini A, Ardinghi C, Carraro F, Franchi A, Paglierani M, Tarantini F, Ketabchi S, Cirino G, Hollenberg MD, Geppetti P, Santucci M.
    Hum Pathol; 2005 Jun; 36(6):676-85. PubMed ID: 16021575
    [Abstract] [Full Text] [Related]

  • 19. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions.
    Demirkan NC, Kesen Z, Akdag B, Larue L, Delmas V.
    Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions.
    Gambichler T, Rotterdam S, Radkowski K, Altmeyer P, Kreuter A.
    Am J Clin Pathol; 2009 May; 131(5):710-4. PubMed ID: 19369632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.